Cancer associated fibroblasts (CAFs) in tumor microenvironment.

Cancer associated fibroblasts (CAFs) is one of the most crucial components of the tumor microenvironment which promotes the growth and invasion of cancer cells by various mechanisms. CAFs demonstrate a high degree of heterogeneity due to their various origins; however, many distinct morphological features and physiological functions of CAFs have been identified. It is becoming clear that the crosstalk between the cancer cells and the CAFs plays a key role in the progression of cancer, and understanding this mutual relationship would eventually enable us to treat cancer patients by targeting CAFs. In this review, we will discuss the latest findings on the role of CAFs in tumorigenesis and metastasis as well as potential therapeutic implication of CAFs.

[1]  S. Forbes,et al.  The bone marrow functionally contributes to liver fibrosis. , 2006, Gastroenterology.

[2]  J. Raingeaud,et al.  Interleukin‐4 downregulates TNFα‐induced IL‐8 production in keratinocytes , 2005 .

[3]  Takeshi Watanabe,et al.  PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism , 2004, Cancer Research.

[4]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[5]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[6]  S. Larson,et al.  A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  F. Anglani,et al.  TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. , 2006, International journal of experimental pathology.

[8]  Olivier De Wever,et al.  Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.

[9]  E. Bruyneel,et al.  Tenascin‐C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  R. Serra,et al.  TGF-β in Mammary Gland Development and Breast Cancer , 2003 .

[11]  Z. Werb,et al.  ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.

[12]  Susan Halabi,et al.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. , 2003, The New England journal of medicine.

[13]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[14]  P. Adegboyega,et al.  Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[15]  A. Canutescu,et al.  Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth , 2005, Molecular Cancer Therapeutics.

[16]  D. Powell,et al.  Powell, D. W. et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9 , 1999 .

[17]  Z. Werb,et al.  Coevolution of cancer and stromal cellular responses. , 2005, Cancer cell.

[18]  A. Multani,et al.  Can cancer cells transform normal host cells into malignant cells? , 1997, British Journal of Cancer.

[19]  H. Moses,et al.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, The Journal of experimental medicine.

[20]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[21]  C. Iacobuzio-Donahue,et al.  Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Houghton,et al.  Tumor microenvironment: The role of the tumor stroma in cancer , 2007, Journal of cellular biochemistry.

[23]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[24]  M. Bissell,et al.  Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. , 2003, The American journal of pathology.

[25]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[26]  R. Bucala,et al.  Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts , 1991, The Journal of experimental medicine.

[27]  Seung‐Mo Hong,et al.  Pancreatic cancer associated fibroblasts display normal allelotypes , 2008, Cancer biology & therapy.

[28]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[29]  Ma Dong,et al.  Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .

[30]  G. Pasquinelli,et al.  Smooth muscle cell differentiation in mammary stromo‐epithelial lesions with evidence of a dual origin: stromal myofibroblasts and myoepithelial cells , 2003, Histopathology.

[31]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[32]  M. Korc,et al.  Connective tissue growth factor–specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer , 2006, Molecular Cancer Therapeutics.

[33]  B. Fingleton.  Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects , 2003, Expert opinion on therapeutic targets.

[34]  Olivier De Wever,et al.  Stromal myofibroblasts are drivers of invasive cancer growth , 2008, International journal of cancer.

[35]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[36]  E. Kubista,et al.  MMP-2 and MMP-9 Expression in Breast Cancer-Derived Human Fibroblasts is Differentially Regulated by Stromal-Epithelial Interactions , 2002, Breast Cancer Research and Treatment.

[37]  H. Kiaris,et al.  Fibroblast independency in tumors: implications in cancer therapy. , 2008, Future oncology.

[38]  M. Barcellos-Hoff.  Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. , 1993, Cancer research.

[39]  N. Zvaifler.  Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases , 2006, Arthritis research & therapy.

[40]  A. Saalbach,et al.  Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase‐1 (MMP‐1) and intercellular adhesion molecule‐1 (ICAM‐1) in vitro , 2000, Experimental dermatology.

[41]  H. Rodemann,et al.  Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  Sean J. Morrison,et al.  Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life , 2008, Cell.

[43]  B. Eyden.  The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine , 2007, Journal of cellular and molecular medicine.

[44]  B. Hogan,et al.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Berking,et al.  Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil , 2003, Oncogene.

[46]  G. Gabbiani,et al.  Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. , 2001, Journal of cell science.

[47]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[48]  J. Dixon,et al.  PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy* , 2002, The Journal of Biological Chemistry.

[49]  J. Salles,et al.  A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia , 2006, Oncogene.

[50]  H. Kobayashi,et al.  A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis. , 1998, European journal of biochemistry.

[51]  S. Kondo,et al.  Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells , 2006, Molecular Cancer Therapeutics.

[52]  G. Anderson,et al.  Lymphostromal interactions in thymic development and function , 2001, Nature Reviews Immunology.

[53]  A. Bezjak,et al.  Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[55]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[56]  H. Wajant,et al.  Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted Activation* , 2003, Journal of Biological Chemistry.

[57]  S. Lemeshow,et al.  Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.

[58]  V. Yong,et al.  Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. , 2002, Brain : a journal of neurology.

[59]  M. Chevallier,et al.  Distribution of the major connective matrix components of the stromal reaction in breast carcinoma. An immunohistochemical study. , 1987, Cellular and molecular biology.

[60]  Robert D. Cardiff,et al.  Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.

[61]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[62]  J. Raingeaud,et al.  Interleukin-4 downregulates TNFalpha-induced IL-8 production in keratinocytes. , 2005, FEBS letters.

[63]  F. Anglani,et al.  TGFβ1 induces epithelial–mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture , 2006 .

[64]  M J Bissell,et al.  Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. , 1998, The American journal of pathology.

[65]  L. Seymour,et al.  A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study. , 2006, Gynecologic oncology.

[66]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[67]  P. Glazer,et al.  Mutagenesis induced by the tumor microenvironment. , 1998, Mutation research.

[68]  A. Balmain,et al.  Metastasis is driven by sequential elevation of H-ras and Smad2 levels , 2002, Nature Cell Biology.

[69]  M. Bissell,et al.  The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion , 2001, Breast Cancer Research.

[70]  M. Alison,et al.  Bone marrow and tumour stroma: an intimate relationship , 2006, Hematological oncology.

[71]  F. Sallusto,et al.  Chemokines and leukocyte traffic , 2008, Nature Immunology.

[72]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[73]  C. Lamers,et al.  A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients , 2004, British Journal of Cancer.

[74]  A. Desmoulière,et al.  Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity , 2004, Virchows Archiv.

[75]  I. Poola,et al.  Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis , 2005, Nature Medicine.

[76]  M. Bissell,et al.  The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. , 1993, Epithelial cell biology.

[77]  Z. Werb,et al.  Location, location, location: the cancer stem cell niche. , 2007, Cell stem cell.

[78]  Howard Y. Chang,et al.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation , 2006, Proceedings of the National Academy of Sciences.

[79]  J. Barciszewski,et al.  Suppression of human brain tumor with interference RNA specific for tenascin-C , 2006, Cancer biology & therapy.

[80]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[81]  R. Crystal,et al.  Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. , 1998, Human gene therapy.

[82]  M. Grigorian,et al.  Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. , 2005, Cancer research.

[83]  J. Lord,et al.  Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. , 2001, Trends in immunology.

[84]  Xunbin Wei,et al.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.

[85]  Terry J. Smith,et al.  Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. , 2003, The American journal of pathology.

[86]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[87]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[88]  A. Ostman,et al.  Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? , 2004, Lung cancer.

[89]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[90]  A. Harris,et al.  Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.

[91]  O. Petersen,et al.  Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[92]  Satoshi Matsumoto,et al.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.

[93]  T. Hunt,et al.  Bone Marrow Contribution to Tumor-Associated Myofibroblasts and Fibroblasts , 2004, Cancer Research.

[94]  R. Clark,et al.  In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface , 1984, The Journal of cell biology.

[95]  B. Roufogalis,et al.  Molecular and cellular regulators of cancer angiogenesis. , 2007, Current cancer drug targets.

[96]  K. Matsumoto,et al.  Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. , 1997, Cancer research.

[97]  M. Rothenberg,et al.  Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors , 2005, Cancer Chemotherapy and Pharmacology.

[98]  M J Bissell,et al.  The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. , 2001, Development.

[99]  M. Grigorian,et al.  Suppression of Tumor Development and Metastasis Formation in Mice Lacking the S 100 A 4 ( mts 1 ) , 2005 .

[100]  U. Gehling,et al.  Tumorigenesis and Neoplastic Progression Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment , 2010 .

[101]  C. B. Alexander,et al.  Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. , 2005, The American journal of pathology.

[102]  T. Ng,et al.  A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[103]  Adrian L Harris,et al.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. , 2006, Cancer research.

[104]  L. Orci,et al.  Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[105]  S. Hayward,et al.  Role of stroma in carcinogenesis of the prostate. , 2002, Differentiation; research in biological diversity.

[106]  S. Soker,et al.  Characterization of Adult Prostatic Progenitor/Stem Cells Exhibiting Self‐Renewal and Multilineage Differentiation , 2008, Stem cells.

[107]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[108]  R. Kalluri,et al.  The role of endothelial-to-mesenchymal transition in cancer progression , 2008, British Journal of Cancer.

[109]  M. Loeffler,et al.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.

[110]  David Botstein,et al.  Diversity, topographic differentiation, and positional memory in human fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  K. Seibert,et al.  Role of inducible cyclooxygenase (COX-2) in inflammation. , 1994, Receptor.

[112]  M. Salmon,et al.  Fibroblasts as novel therapeutic targets in chronic inflammation , 2008, British journal of pharmacology.

[113]  F. Falciani,et al.  Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns , 2003, Thrombosis and Haemostasis.

[114]  O. Petersen,et al.  A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts , 1996, The Journal of cell biology.

[115]  S. Itohara,et al.  In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture. , 2002, Pharmacological research.

[116]  R. Schneider-Broussard,et al.  Prostate cancer stem/progenitor cells: Identification, characterization, and implications , 2007, Molecular carcinogenesis.

[117]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[118]  M. Herlyn,et al.  Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[119]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[120]  J. Scholefield,et al.  Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial , 2002, British Journal of Cancer.

[121]  L. Old,et al.  Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[122]  W. Schürch,et al.  Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.

[123]  C. Eng,et al.  Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. , 2007, JAMA.

[124]  R. Weinberg,et al.  Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[125]  J. Healey,et al.  Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[126]  D. Miles,et al.  Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.

[127]  G. Risbridger,et al.  Minireview: regulation of prostatic stem cells by stromal niche in health and disease. , 2008, Endocrinology.

[128]  R. Coleman,et al.  Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[129]  Yong Li,et al.  Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer , 2005, Clinical & Experimental Metastasis.

[130]  M. Smyth,et al.  Immune surveillance of tumors. , 2007, The Journal of clinical investigation.

[131]  Liang Xie,et al.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.

[132]  Feng Yang,et al.  Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. , 2005, Cancer research.

[133]  A B West,et al.  Myofibroblasts. I. Paracrine cells important in health and disease. , 1999, The American journal of physiology.

[134]  W. Frankel,et al.  Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.

[135]  K. Imai.  [Matrix metalloproteinases and cancer cell invasion and metastasis]. , 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[136]  E. Sahai,et al.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.

[137]  K. Pfizenmaier,et al.  Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein. , 2001, Journal of biotechnology.